OXIS International, Inc. (OXIS) Release: ERGOFLEX(TM) Joint Pain Study Published Online in Preventive Medicine
3/28/2012 9:37:08 AM
BEVERLY HILLS, Calif., March 28, 2012 (GLOBE NEWSWIRE) -- OXIS International, Inc. (OXIS.OB) (Paris:OXI) announced today that a Joint Pain and Mobility study demonstrating highly significant short and long-term benefits for joint health using its Patent Pending ERGOFLEX™ with proprietary EGT™ (99% pure L-ergothioneine) complex, has been published in the peer-reviewed journal, Preventive Medicine. EGT is a natural anti-oxidant, anti-inflammatory nutrient, required by humans as well as all animals, but only available through diet until now. EGT is the only known intelligent anti-oxidant to be actively transported into cells under stress. ERGOFLEX is the first dietary supplement to incorporate EGT and the only joint health complex containing this unique intelligent antioxidant. ERGOFLEX is specifically formulated to support the body's natural ability to fight the pain of joint inflammation while providing support for the structural integrity and lubrication of joints.
comments powered by